BIOVENTUS INC. - CLASS A COMMON STOCK

Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference

07 1 2025 08:00:01 提供 Nasdaq GlobeNewswire

Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

02 1 2025 08:00:00 提供 Nasdaq GlobeNewswire

Bioventus Reports Third Quarter Financial Results

05 11 2024 07:30:00 提供 Nasdaq GlobeNewswire

Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024

29 10 2024 07:30:00 提供 Nasdaq GlobeNewswire

Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

01 10 2024 09:00:01 提供 Nasdaq GlobeNewswire

Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference

07 8 2024 16:15:00 提供 Nasdaq GlobeNewswire

Bioventus Reports Second Quarter Financial Results

06 8 2024 07:30:00 提供 Nasdaq GlobeNewswire

Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024

30 7 2024 07:30:00 提供 Nasdaq GlobeNewswire

Bioventus Reports First Quarter Financial Results

07 5 2024 07:00:01 提供 Nasdaq GlobeNewswire

Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024

29 4 2024 07:30:00 提供 Nasdaq GlobeNewswire

Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results

12 3 2024 07:30:01 提供 Nasdaq GlobeNewswire

Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024

04 3 2024 08:00:00 提供 Nasdaq GlobeNewswire

Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility

18 1 2024 16:15:00 提供 Nasdaq GlobeNewswire

Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole

12 1 2024 16:15:00 提供 Nasdaq GlobeNewswire

Bioventus Names Robert Claypoole as President and Chief Executive Officer

19 12 2023 16:30:00 提供 Nasdaq GlobeNewswire

Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis

06 12 2023 08:00:00 提供 Nasdaq GlobeNewswire

Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance

07 11 2023 07:00:01 提供 Nasdaq GlobeNewswire

Bioventus to Report Third Quarter of Fiscal Year 2023 Financial Results on November 7, 2023

31 10 2023 07:00:00 提供 Nasdaq GlobeNewswire

Bioventus to Present at the Cantor Global Healthcare Conference

19 9 2023 21:52:45 提供 Nasdaq GlobeNewswire

Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

06 9 2023 16:30:00 提供 Nasdaq GlobeNewswire